OTCMKTS:PRVCF PreveCeutical Medical (PRVCF) Stock Price, News & Analysis $0.02 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartShort Interest About PreveCeutical Medical Stock (OTCMKTS:PRVCF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PreveCeutical Medical alerts:Sign Up Key Stats Today's Range$0.0195▼$0.019550-Day Range$0.01▼$0.0252-Week Range$0.01▼$0.02Volume4,500 shsAverage Volume30,415 shsMarket Capitalization$10.56 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada.Read More… Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Receive PRVCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address PRVCF Stock News HeadlinesPreveCeutical Medical Inc PRVCFMarch 15, 2024 | morningstar.comPreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD ApplicationSeptember 18, 2023 | finance.yahoo.comCharles Payne Wants You Prepared for Q4Charles Payne Wants You Prepared for Q4 Because as we look toward 2025, there's no denying that market volatility, inflation, and recession fears are top of mind for every investor Now more than ever, it's crucial to have a solid plan for navigating uncertainty and coming out ahead. November 5, 2024 | Unstoppable Prosperity (Ad)PreveCeutical Showcases Dynamic Evolution in AI StrategySeptember 12, 2023 | finance.yahoo.comPreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses ThereofJune 28, 2023 | finance.yahoo.comPreveCeutical Medical - Sol-Gel and Uses thereof Patent UpdateMay 30, 2023 | finance.yahoo.comPreveCeutical Medical Launches Clinical Artificial Intelligence DivisionApril 24, 2023 | finance.yahoo.comPreveCeutical Medical Announces Live Interactive Q&A Video ConferenceApril 20, 2023 | finance.yahoo.comSee More Headlines PRVCF Stock Analysis - Frequently Asked Questions How have PRVCF shares performed this year? PreveCeutical Medical's stock was trading at $0.0181 on January 1st, 2024. Since then, PRVCF shares have increased by 7.7% and is now trading at $0.0195. View the best growth stocks for 2024 here. How do I buy shares of PreveCeutical Medical? Shares of PRVCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Company Calendar Today11/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:PRVCF CUSIPN/A CIKN/A Webwww.preveceutical.com Phone(604) 416-7777Fax778-945-6290EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-940,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-668.63% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-1.95Miscellaneous Outstanding Shares541,700,000Free FloatN/AMarket Cap$10.56 million OptionableNot Optionable Beta0.55 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (OTCMKTS:PRVCF) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PreveCeutical Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PreveCeutical Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRVCF Stock Alerts